MedPath

Effect of topical formulation of Ajwain essential oil in treatment of Acne

Phase 2
Conditions
Acne.
Acne, unspecified
Registration Number
IRCT2016031126938N3
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
15
Inclusion Criteria

Age of 20-58 years; Mild to Moderate Acne affection without cystic acne; having at least 15 inflamed and 15 non-inflamed acne lesions on the face. Exclusion criteria: History of acute disease of patient or any type of sensitivity or allergy to the components of medication; Using topical anti-acne medications which include vitamin A, Alpha or Beta-hydroxy acids, Retin A, Antibiotics or benzoyl peroxide during 4 weeks before the beginning of intervention; Using oral antibiotics for treating acne during 1 month before the beginning of intervention; Using systemic isotretinoin or application of laser therapy, microdermabrasion and chemical peeling during 6 month before the beginning of intervention; Pregnant or Lactating women; Women who want to be pregnant in the next 6 month after the beginning of intervention; Patients who are exposed to long-term and direct sunlight or UV lamps, without skin protection, due to their occupation; Patients who do not follow the protocol of treatment.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath